Presented By:Oludare Odumosu, Chief Scientific Officer & Executive Vice President, Pharmaceutical Division, Ilera Healthcare
The FDA is coming! With the popularity of state-wide medical cannabis legalization, it is not a question of if FDA oversight will happen, but when. In the meantime, what can MMJ companies do to prepare themselves for coming regulations and oversight? What can be learned from the pharmaceutical industry in regards to product development, testing and quality control? Ilera Healthcare’s Chief Scientific Officer Dr. Oludare Odumosu will speak to why the MMJ industry needs to start preparing for the FDA now and what can be done to insure viability in regards to future oversight.